Estey E - Search Results

1

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.

Kornblau SM, Andreeff M, Hu SX, Xu HJ, Patel S, Theriault A, Koller C, Kantarjian H, Estey E, Deisseroth AB, Benedict WF. Kornblau SM, et al. Among authors: estey e. Clin Cancer Res. 1998 Aug;4(8):1955-63. Clin Cancer Res. 1998. PMID: 9717825

2

Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.

Kornblau SM, Xu HJ, del Giglio A, Hu SX, Zhang W, Calvert L, Beran M, Estey E, Andreeff M, Trujillo J, et al. Kornblau SM, et al. Among authors: estey e. Cancer Res. 1992 Sep 1;52(17):4587-90. Cancer Res. 1992. PMID: 1511426

3

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.

Estey E, Thall PF, Kantarjian H, O'Brien S, Koller CA, Beran M, Gutterman J, Deisseroth A, Keating M. Estey E, et al. Blood. 1992 May 1;79(9):2246-55. Blood. 1992. PMID: 1571541 Free article.

4

Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia.

O'Brien S, Kantarjian H, Estey E, Koller C, Beran M, McCredie K, Keating M. O'Brien S, et al. Among authors: estey e. Cancer. 1991 Aug 15;68(4):691-4. doi: 10.1002/1097-0142(19910815)68:4<691::aid-cncr2820680404>3.0.co;2-z. Cancer. 1991. PMID: 1855168

5

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.

Estey E, Thall P, Andreeff M, Beran M, Kantarjian H, O'Brien S, Escudier S, Robertson LE, Koller C, Kornblau S, et al. Estey E, et al. J Clin Oncol. 1994 Apr;12(4):671-8. doi: 10.1200/JCO.1994.12.4.671. J Clin Oncol. 1994. PMID: 7512125 Clinical Trial.

6

Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance.

Kornblau SM, Thall P, Huh YO, Estey E, Andreeff M. Kornblau SM, et al. Among authors: estey e. Leukemia. 1995 Oct;9(10):1735-41. Leukemia. 1995. PMID: 7564518

7

Phase II study of interleukin-6 in patients with smoldering relapse of acute myelogenous leukemia.

Estey E, Andreeff M. Estey E, et al. Leukemia. 1995 Sep;9(9):1440-3. Leukemia. 1995. PMID: 7658709 Clinical Trial.

8

Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia.

Kornblau SM, Xu HJ, Zhang W, Hu SX, Beran M, Smith TL, Hester J, Estey E, Benedict WF, Deisseroth AB. Kornblau SM, et al. Among authors: estey e. Blood. 1994 Jul 1;84(1):256-61. Blood. 1994. PMID: 8018920 Free article.

9

Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.

Kornblau SM, Gandhi V, Andreeff HM, Beran M, Kantarjian HM, Koller CA, O'Brien S, Plunkett W, Estey E. Kornblau SM, et al. Among authors: estey e. Leukemia. 1996 Oct;10(10):1563-9. Leukemia. 1996. PMID: 8847890 Clinical Trial.

10

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

Estey E, Thall PF, Pierce S, Kantarjian H, Keating M. Estey E, et al. J Clin Oncol. 1997 Feb;15(2):483-90. doi: 10.1200/JCO.1997.15.2.483. J Clin Oncol. 1997. PMID: 9053469 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

743 results

Search Page

Filters